No photo of Olli Mikael Carpen
  • PL 21 (Haartmaninkatu 3)

    00014

    Finland

1994 …2020
If you made any changes in Pure these will be visible here soon.

Personal profile

Fields of Science

  • 3111 Biomedicine

International and National Collaboration Publications and projects within past five years.

Publications 1994 2020

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors

Kaipio, K., Chen, P., Roering, P., Huhtinen, K., Mikkonen, P., Östling, P., Lehtinen, L., Mansuri, N., Korpela, T., Potdar, S., Hynninen, J., Auranen, A., Grénman, S., Wennerberg, K., Hautaniemi, S. & Carpén, O., Feb 2020, In : Journal of Pathology. 250, 2, 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Performance of Finnish biobanks in nationwide pulmonary carcinoid tumour research

Vesterinen, T., Salmenkivi, K., Mustonen, H., Kuopio, T., Lappi-Blanco, E., Paavonen, T., Vainio, P., Knuuttila, A., Carpén, O., Haglund, C. & Arola, J., 2020, In : Virchows Archiv. 476, p. 273-283 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Biopankit yksilöllistetyn lääkehoidon apuna

Carpen, O., 2019, In : Sic! Lääketietoa Fimeasta. 9, 3-4, p. 14-15 2 p.

Research output: Contribution to journalArticleProfessional

BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas

Manninen, A. A., Gardberg, M., Juteau, S., Ilmonen, S., Jukonen, J., Andersson, N. & Carpen, O., 30 Apr 2019, In : PLoS One. 14, 4, 13 p., 0216043.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

CA 19-9 doubling time in pancreatic cancer as a predictor of venous thromboembolism: a hospital database study

Peippo, M. H., Kurki, S., Seppänen, H., Lassila, R. & Carpen, O., 24 Oct 2019, In : Acta Oncologica. 5 p.

Research output: Contribution to journalLetterScientific